Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01821534 · ClinicalTrials.gov registry record

Reliability of a Masseter Muscle Prominence Scale and Lower Facial Shape Classification

A clinical trial, sponsored by Allergan.

Completed
Registry status
201
Enrollment target

NCT01821534: Completed study, sponsored by Allergan.

NCT01821534 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 201 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01821534 has completed, sponsored by Allergan.

COMPLETED
Registry status
201 participants
Enrollment target

Study Summary

This study will evaluate the inter-rater and intra-rater reliability of a Masseter Muscle Prominence Scale for evaluating a patient's muscle prominence and a Lower Shape Classification for evaluating a patient's lower facial shape.

Primary Outcome

The MMPS is an ordinal tool to assess the masseter muscle prominence (jaw muscle) for each side of the face from 1=minimal to 5=very marked. Inter-rater (among raters) reliability was calculated separately for the left and right side of the face using Kendall's coefficient of concordance (Kendall's W). Kendall W statistics overall for the left and right sides of the face were derived using the average of assessment 1 and assessment 2 rounded to the nearest whole integer for each subject and each

Interventions

  • OTHER No Intervention

Trial Details

FieldValue
Enrollment Target 201 participants
Start Date 2013-03
Est. Completion 2013-05
Allergan

314 total trials

What the finished NCT01821534 record still lists

NCT01821534 is an observational study that tracks outcomes without assigning an intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.

NCT01821534 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01821534 about?

NCT01821534 is a clinical study titled "Reliability of a Masseter Muscle Prominence Scale and Lower Facial Shape Classification". This study will evaluate the inter-rater and intra-rater reliability of a Masseter Muscle Prominence Scale for evaluating a patient's muscle prominence and a Lower Shape Classification for evaluating a patient's lower facial shape.

What is the current status of trial NCT01821534?

This trial is currently completed. The enrollment target is 201 participants. The study started on 2013-03. Estimated completion is 2013-05.

What interventions are being tested in trial NCT01821534?

The interventions under investigation include: No Intervention (OTHER).

Who is sponsoring clinical trial NCT01821534?

This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04422652 · 201 participants · Phase 2

    Combination of Novel Therapies for CKD Comorbid Depression

  • NCT05327114 · 201 participants · Phase 2

    Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • NCT06099769 · 201 participants · Phase 2

    A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

  • NCT06274528 · 201 participants · Phase 2

    DORA and LP in Alzheimer's Disease Biomarkers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01821534, the US trial registry maintained by the National Library of Medicine. NCT01821534 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.